Reducing phaco-induced apoptosis

Article

Cell apoptosis caused by free-radical formation during phacoemulsification can be mediated by the introduction of ascorbic acid, according to a study published in the December 2008 issue of the Journal of Cataract & Refractive Surgery.

Cell apoptosis caused by free-radical formation during phacoemulsification can be mediated by the introduction of ascorbic acid, according to a study published in the December 2008 issue of the Journal of Cataract & Refractive Surgery.

Naphtali Savion, PhD of Tel-Aviv University, Israel and colleagues assessed cell apoptosis in bovine corneal endothelial cells (CECs), which were cultured on gas-permeable flexible membranes, and then exposed to phacoemulsification. As a control, the researchers also examined cell apoptosis in CECs exposed to hydrogen peroxide for a period of 48 hours.

The researchers found that cell apoptosis increased from 45±12 apoptic nuclei per square millimetre before phacoemulsification to 334±29 48 hours postoperatively. Following 48 hours' exposure to hydrogen peroxide, apoptosis was 345±6 (H2O2 concentration, 50 µM) and 376±1 (H2O2 concentration, 100 µM). Adding ascorbic acid decreased the mean 48-hour post-phaco apoptosis level to 219±15 (ascorbic acid concentration, 1 mM) and 130±29 (ascorbic acid concentration, 10 mM), although applying shear forces up to 2000 seconds1 for 60 minutes did not alter the rate of apoptosis.

The researchers concluded that the increased rate of cell apoptosis that results from phacoemulsification is likely to be caused by free radical formation, and can therefore be modified through the application of ascorbic acid.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.